NCT06500377 Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors
| NCT ID | NCT06500377 |
| Status | Recruiting |
| Phase | — |
| Sponsor | City of Hope Medical Center |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2024-06-17 |
| Primary Completion | 2027-03-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2024-06-17 with a primary completion date of 2027-03-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial compares the impact of four types of meditation practices, breathing only, focused attention only, mindfulness only, and breathing, focused attention and mindfulness combined, for relaxation in cancer survivors. Studies show that many patients with cancer experience stress and anxiety. Meditation therapy uses a variety of techniques, such as breathing, sound, or movement, that may help to decrease distress and anxiety and enhance the health and quality of life of patients with cancer. The trial is being done to find out how meditation can help cancer survivors feel relaxed and attain a peaceful state of mind.
Eligibility Criteria
Inclusion Criteria: * Documented written informed consent of the participant * Age: ≥ 18 years * Ability to understand and fluently speak English or Spanish * No previous training in mind-body relaxation techniques including meditation, yoga, tai chi, qigong, guided imagery, mindfulness-based stress reduction, hypnosis, or cognitive behavior therapy, that exceeds 3 hours. Additionally, no regular practice of mind-body relaxation techniques, or formal experience with mind-body relaxation techniques within the past 12 months * Visual Analog Scale (VAS) anxiety score of \> 3 from a range from 0 to 10. A "0" means the lowest anxiety score and a "10" means the highest anxiety score * Long-term cancer survivors who received surgery to treat their cancer ( \> 6 months since last treatment) with no history of chemotherapy, radiation therapy, or other systemic therapy (e.g., hormonal therapy) and/or have completely recovered from surgery OR patients identified as having pre-cancerous lesions that have been surgically treated (e.g., colon polyp that has been removed) * Willingness to: * Provide salivary alpha-amylase sample * Complete stress tests and study questionnaires * Be monitored with a Bispectral Index (BIS) device Exclusion Criteria: * Inability to complete study required time and procedures as outlined in the study procedures section of the protocol * Must not have had previous serious illnesses that affect neurological functioning such as strokes, heart attacks, Parkinson disease, etc * Ongoing active psychiatric condition, depressive/bi-polar related disorders, anxiety, psychosis disorders, or substance use that may interfere with the study including panic disorder, major depression, schizophrenia, and bipolar disease * Active cancer * Cancer survivors who have received chemotherapy, radiation therapy, or any other systemic treatment (e.g., hormonal therapy) * Women who are pregnant
Contact & Investigator
Richard T Lee
PRINCIPAL INVESTIGATOR
City of Hope Medical Center
Frequently Asked Questions
Who can join the NCT06500377 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hematopoietic and Lymphatic System Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06500377 currently recruiting?
Yes, NCT06500377 is actively recruiting participants. Visit ClinicalTrials.gov or contact City of Hope Medical Center to inquire about joining.
Where is the NCT06500377 trial being conducted?
This trial is being conducted at Duarte, United States, Irvine, United States.
Who is sponsoring the NCT06500377 clinical trial?
NCT06500377 is sponsored by City of Hope Medical Center. The principal investigator is Richard T Lee at City of Hope Medical Center. The trial plans to enroll 44 participants.